Skip to main content
logo
Charles River Laboratories International, Inc. (CRL)
NYSE: CRL · Real-Time Price · USD
179.11
-1.04 (-0.58%)
At close: Oct 30, 2025, 4:00 PM EDT
179.11
0.00 (0.00%)
After-hours: Oct 30, 2025, 4:10 PM EDT

CRL Revenue

Charles River Laboratories International had revenue of $1.03B in the quarter ending June 28, 2025, with 0.59% growth. This brings the company's revenue in the last twelve months to $4.03B, down -1.21% year-over-year. In the year 2024, Charles River Laboratories International had annual revenue of $4.05B, down -1.92%.

Revenue (ttm)
$4.03B
Revenue Growth
-1.21%
P/S Ratio
2.25
Revenue / Employee
$200,429
Employees
20,100
Market Cap
8.81B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 28, 20244.05B-79.42M-1.92%
Dec 30, 20234.13B153.35M3.86%
Dec 31, 20223.98B435.90M12.31%
Dec 25, 20213.54B616.23M21.08%
Dec 26, 20202.92B302.71M11.55%
Dec 28, 2019 Pro Pro Pro
Dec 29, 2018 Pro Pro Pro
Dec 30, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 26, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
UnitedHealth Group422.82B
Johnson & Johnson92.15B
Merck & Co.63.62B
AbbVie58.33B
AstraZeneca56.50B
Novartis AG55.19B
Eli Lilly and Company53.26B
Novo Nordisk49.11B
Revenue Rankings

CRL News

More News